Sökning: L773:0161 5505 >
Feasibility of Affi...
Feasibility of Affibody-Based Bioorthogonal Chemistry Mediated Radionuclide Pretargeting
-
- Altai, Mohamed (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
-
- Perols, Anna (författare)
- KTH,Proteinteknologi
-
- Tsourma, Maria (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
-
visa fler...
-
- Mitran, Bogdan (författare)
- Uppsala universitet,Plattformen för preklinisk PET,Anna Orlova
-
- Honarvar, Hadis (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
-
Robillard, Marc (författare)
-
Rossin, Raffaella (författare)
-
ten Hoeve, Wolter (författare)
-
- Lubberink, Mark (författare)
- Uppsala universitet,Radiologi
-
- Orlova, Anna (författare)
- Uppsala universitet,Plattformen för preklinisk PET,Anna Orlova
-
- Karlström, Amelie Eriksson (författare)
- KTH,Proteinteknologi
-
- Tolmachev, Vladimir (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
-
visa färre...
-
(creator_code:org_t)
- 2015-12-10
- 2016
- Engelska.
-
Ingår i: Journal of Nuclear Medicine. - : SOC NUCLEAR MEDICINE. - 0161-5505 .- 1535-5667 .- 2159-662X. ; 57:3, s. 431-436
- Relaterad länk:
-
http://jnm.snmjourna...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.2...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Affibody molecules constitute a new class of probes for radionuclide tumor targeting. The small size of Affibody molecules is favorable for rapid localization in tumors and clearance from circulation. However, high renal reabsorption of Affibody molecules prevents the use of residualizing radiometals, including several promising low-energy (beta- and alpha-emitters, for radionuclide therapy. We tested a hypothesis that Affibody-based pretargeting mediated by a bioorthogonal interaction between trans-cyclooctene (TCO) and tetrazine would provide higher accumulation of radiometals in tumor xenografts than in the kidneys. Methods: TCO was conjugated to the anti-human epidermal growth factor receptor 2 (HER2) Affibody molecule Z(2395). DOTA-tetrazine was labeled with In-111 and Lu-177. In vitro pretargeting was studied in HER2-expressing SKOV-3 and BT474 cell lines. In vivo studies were performed on BALB/C nu/nu mice bearing SKOV-3 xenografts. Results: I-125-Z(2395)-TCO bound specifically to HER2-expressing cells in vitro with an affinity of 45 +/- 16 pM. In-111-tetrazine bound specifically and selectively to Z(2325)-TCO pretreated cells. In vivo studies demonstrated HER2-specific I-125-Z(2395)-TCO accumulation in xenografts. TCO-mediated In-111-tetrazine localization was shown in tumors, when the radiolabeled tracer was injected 4 h after an injection of Z(2395)-TCO. At 1 h after injection, the tumor uptake of In-111-tetrazine and Lu-177-tetrazine was approximately 2-fold higher than the renal uptake. Pretargeting provided more than a 56-fold reduction of renal uptake of In-111 in comparison with direct targeting. Conclusion: The feasibility of Affibody-based bioorthogonal chemistry-mediated pretargeting was demonstrated. The use of pre-targeting provides a substantial reduction of radiometal accumulation in kidneys, creating preconditions for palliative radionuclide therapy.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- affibody
- tetrazine
- trans-cyclooctene
- radionuclide pretargeting
- engineered scaffold protein
- radionuclide therapy
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Altai, Mohamed
-
Perols, Anna
-
Tsourma, Maria
-
Mitran, Bogdan
-
Honarvar, Hadis
-
Robillard, Marc
-
visa fler...
-
Rossin, Raffaell ...
-
ten Hoeve, Wolte ...
-
Lubberink, Mark
-
Orlova, Anna
-
Karlström, Ameli ...
-
Tolmachev, Vladi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Radiologi och bi ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
Journal of Nucle ...
- Av lärosätet
-
Kungliga Tekniska Högskolan
-
Uppsala universitet